Quality of Life and Lung Function on Post Covid-19 Patient

Study Overview
=================
Brief Summary
-----------------
Gaining a greater understanding of how the breathing exercise combined with aerobic and strengthening exercises will affects lung function and quality of life in post covid-19 persons

Detailed Description
-----------------
this will improve exercise prescription guidelines relevant to this post covid-19. Therefore, the purpose of this work was determining the effect of breathing exercise combined with aerobic and strengthening exercises in improve chest expansion, lung function and quality of life in post covid-19 persons.

Official Title
-----------------
Effect of Breathing Exercise on Chest Expansion, Quality of Life and Lung Function on Post Covid-19 Patient: A Randomized Controlled Trial

Conditions
-----------------
COVID-19

Intervention / Treatment
-----------------
* Other: breathing exercise, Aerobic exercises


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Female. Age from 20 to 30 years old. - Body mass index (BMI) 19 to 24 kg/m2.- Non-smoker- Recovered from COVID-19 over the past 12 months. - They are experiencing mild to moderate symptoms without any complications. - Able to use online communication programs. Exclusion Criteria: - Anyone who does regular physical exercise. history of acute illness, asthma, pulmonary fibrosis, hypertension, diabetes disease. hypoxemia in rest.

Ages Eligible for Study
-----------------
Minimum Age: 20 Years
Maximum Age: 30 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: study group<br>Will receive diaphragmatic breathing with pursed lips as (breathing exercise), They will instruct to perform 3 different conditions will be registered: (1) 6 min of quiet breathing (3 sets of 2 min each), defined as spontaneous breathing pattern; (2) 6 min of diaphragmatic breathing (3 sets of 2 min each); and (3) 6 min of diaphragmatic breathing plus pursed-lips breathing (3 sets of 2 min each). For aerobic exercises: Will include the following exercises: walking, cycling, running and intermittent running. The exercises will perform for 18-60 minutes for 1-2 sets per week. For resistance exercises: Will include the following 8 exercises: shoulder press, biceps curl, triceps curl, bench press, leg squats, leg press, leg curl and toe raise. The exercises will perform for 60 minutes for 2-3 sets per week. | Other: breathing exercise, Aerobic exercises<br>* 6 min of quiet breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing plus pursed-lips breathing (3 sets of 2 min each).<br>* Other names: resistance exercises;|
| No Intervention: control group<br>not receiving any exercises | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Health-related quality of life, Medical Outcomes Study short-form (SF-36) | assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score. | at baseline | 
| Health-related quality of life, Medical Outcomes Study short-form (SF-36) | assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score. | after 6 weeks | 
| Respiratory function measurement | assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC). | at baseline | 
| Respiratory function measurement | assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC). | after 6 weeks | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Chest expansion measurement | measured with a tape measure at 2 different levels of the rib cage. Measurements will be taken at the maximal inspiration and expiration | at baseline | 
| Chest expansion measurement | measured with a tape measure at 2 different levels of the rib cage. Measurements will be taken at the maximal inspiration and expiration | after 6 weeks | 
| Exercise endurance measurement | measured by the 6-min walk test (6MWT), is the distance one walks within 6 min | at baseline | 
| Exercise endurance measurement | measured by the 6-min walk test (6MWT), is the distance one walks within 6 min | after 6 weeks |